Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
La Revue De Medecine Interne
|
May 2, 2009
[Pneumocystis pneumonia in two breast cancer patients treated with docetaxel: an unusual adverse event of chemotherapy]
G Philippin-Lauridant, F Clatot, O Rigal, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
|
November 25, 2006
[Diagnosis and treatment of soft-tissue tumors]
F Dujardin, M Debled, C Guillemet, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
April 6, 2007
[Carcinosarcoma of the ovary]
M Muller, P-F Dupre, B Lucas, et al.
Gastroenterologie Clinique Et Biologique
|
June 12, 2010
Optimal treatment with systemic chemotherapy, complete surgical excision and hyperthermic intraperitoneal chemotherapy for a desmoplastic small round cell tumor in an adult male patient
G Lauridant-Philippin, N Ledem, F Lemoine, et al.
Gynecologic Oncology
|
February 24, 2009
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
J E Kurtz, A-C Hardy-Bessard, M Deslandres, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
ESMO Open
|
September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis
M Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
La Revue De Medecine Interne
|
May 2, 2009
[Pneumocystis pneumonia in two breast cancer patients treated with docetaxel: an unusual adverse event of chemotherapy]
G Philippin-Lauridant, F Clatot, O Rigal, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
|
November 25, 2006
[Diagnosis and treatment of soft-tissue tumors]
F Dujardin, M Debled, C Guillemet, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
April 6, 2007
[Carcinosarcoma of the ovary]
M Muller, P-F Dupre, B Lucas, et al.
Gastroenterologie Clinique Et Biologique
|
June 12, 2010
Optimal treatment with systemic chemotherapy, complete surgical excision and hyperthermic intraperitoneal chemotherapy for a desmoplastic small round cell tumor in an adult male patient
G Lauridant-Philippin, N Ledem, F Lemoine, et al.
Gynecologic Oncology
|
February 24, 2009
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
J E Kurtz, A-C Hardy-Bessard, M Deslandres, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
ESMO Open
|
September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis
M Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Page
of 2